JPMorgan Chase & Co. raised its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 63.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 630,644 shares of the business services provider's stock after acquiring an additional 245,086 shares during the quarter. JPMorgan Chase & Co. owned approximately 1.24% of Exponent worth $72,701,000 at the end of the most recent reporting period.
Other hedge funds have also bought and sold shares of the company. Westside Investment Management Inc. acquired a new stake in shares of Exponent during the 3rd quarter valued at about $26,000. Quarry LP acquired a new stake in Exponent in the second quarter valued at approximately $25,000. USA Financial Formulas acquired a new stake in Exponent in the third quarter valued at approximately $60,000. Anchor Investment Management LLC purchased a new stake in shares of Exponent in the third quarter valued at approximately $64,000. Finally, GAMMA Investing LLC raised its stake in shares of Exponent by 64.6% during the 3rd quarter. GAMMA Investing LLC now owns 624 shares of the business services provider's stock worth $72,000 after buying an additional 245 shares during the period. Hedge funds and other institutional investors own 92.37% of the company's stock.
Insider Buying and Selling
In other news, Director Carol Lindstrom sold 1,039 shares of the stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the completion of the sale, the director now directly owns 5,871 shares in the company, valued at $565,494.72. This represents a 15.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Paul R. Johnston sold 1,300 shares of the firm's stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $95.03, for a total transaction of $123,539.00. Following the completion of the transaction, the director now directly owns 59,406 shares in the company, valued at approximately $5,645,352.18. This represents a 2.14 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,339 shares of company stock worth $3,103,065 in the last 90 days. Insiders own 2.10% of the company's stock.
Exponent Stock Performance
Exponent stock traded up $0.99 during trading on Friday, reaching $88.91. The company had a trading volume of 206,713 shares, compared to its average volume of 189,007. The firm has a market capitalization of $4.51 billion, a PE ratio of 42.95 and a beta of 0.70. The firm's 50-day simple moving average is $95.79 and its 200 day simple moving average is $101.84. Exponent, Inc. has a 1-year low of $68.70 and a 1-year high of $115.75.
Exponent Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, December 20th. Stockholders of record on Friday, December 6th were paid a dividend of $0.28 per share. The ex-dividend date of this dividend was Friday, December 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.26%. Exponent's dividend payout ratio is currently 54.11%.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.